CVNA (CVNA) Rule 144 Notice: 10,000-Share Sale and 10b5-1 History
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
The filing is a Rule 144 resale/transfer notice reporting 10,000 shares of Common Stock tied to an exercise of stock options dated 05/01/2026. It lists three prior 10b5-1 sales of 10,000 shares each on 04/01/2026, 03/02/2026, and 02/02/2026 with the proceeds shown for each sale.
Positive
- None.
Negative
- None.
Key Figures
Shares to be sold: 10,000 shares
04/01/2026 10b5-1 sale proceeds: $3,098,610
03/02/2026 10b5-1 sale proceeds: $3,226,689
+1 more
4 metrics
Shares to be sold
10,000 shares
exercise of stock options dated 05/01/2026
04/01/2026 10b5-1 sale proceeds
$3,098,610
10,000 shares sold under 10b5-1 Sales Plan on 04/01/2026
03/02/2026 10b5-1 sale proceeds
$3,226,689
10,000 shares sold under 10b5-1 Sales Plan on 03/02/2026
02/02/2026 10b5-1 sale proceeds
$4,112,724
10,000 shares sold under 10b5-1 Sales Plan on 02/02/2026
Key Terms
Rule 144, 10b5-1 Sales Plan, Exercise of Stock Options
3 terms
Rule 144 regulatory
"Securities To Be Sold Common 05/01/2026 Exercise of Stock Options"
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
10b5-1 Sales Plan regulatory
"10b5-1 Sales Plan for BHJC Trust 300 E. Rio Salado Parkway Tempe AZ"
Exercise of Stock Options financial
"Common 05/01/2026 Exercise of Stock Options Issuer 10000 05/01/2026 Cash"
FAQ
What does the CVNA Rule 144 notice report?
The notice reports 10,000 shares of Common Stock sold following an exercise of stock options on 05/01/2026. It documents prior 10b5-1 sales in February–April 2026 of 10,000 shares each.
Were prior sales made under a trading plan?
Yes. The filing lists prior sales executed under a 10b5-1 Sales Plan on 02/02/2026, 03/02/2026, and 04/01/2026, each for 10,000 shares, with proceeds shown per trade.
What proceeds are shown for the recent 10b5-1 sales?
The filing shows proceeds of $3,098,610, $3,226,689, and $4,112,724 for the three 10b5-1 sales dated 04/01/2026, 03/02/2026, and 02/02/2026, respectively.
Does the filing state the method of sale for the 05/01/2026 transaction?
Yes. The 05/01/2026 transaction is described as an exercise of stock options and the consideration type is listed as Cash in the excerpt.
Is the filing indicating any insider ownership change summary?
The filing documents specific sales and an option exercise totaling 10,000 shares on 05/01/2026 and prior monthly 10b5-1 sales; no aggregate post-transaction ownership figure is provided in the excerpt.